{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:59:53Z","timestamp":1767650393557},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1331\/japha.2009.09522","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T01:24:12Z","timestamp":1247189052000},"page":"566-568","source":"Crossref","is-referenced-by-count":1,"title":["Immunizations against bioterrorism: Smallpox and anthrax"],"prefix":"10.1016","volume":"49","author":[{"given":"Amanda R.","family":"Margolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Grabenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2009.09522_bb0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ajhp\/59.10.923","article-title":"Patient and public concerns in catastrophic circumstances","volume":"59","author":"Grabenstein","year":"2002","journal-title":"Am J Health Syst Pharm."},{"key":"10.1331\/JAPhA.2009.09522_bb0015","series-title":"Emergency preparedness and response: smallpox disease overview","author":"Centers for Disease Control and Prevention","year":"2008"},{"issue":"RR-7","key":"10.1331\/JAPhA.2009.09522_bb0020","first-page":"1","article-title":"Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm Rep."},{"key":"10.1331\/JAPhA.2009.09522_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/524751","article-title":"US civilian smallpox preparedness and response program, 2003","volume":"46","author":"Strikas","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.1331\/JAPhA.2009.09522_bb0030","first-page":"858","article-title":"Vaccines and bioterrorism: smallpox and anthrax","volume":"52","author":"Kimmel","year":"2003","journal-title":"J Fam Pract."},{"key":"10.1331\/JAPhA.2009.09522_bb0035","first-page":"34","article-title":"Ring vaccination versus mass vaccination in event of a smallpox attack","volume":"64","author":"Lau","year":"2005","journal-title":"Hawaii Med J."},{"key":"10.1331\/JAPhA.2009.09522_bb0040","series-title":"Smallpox and Its eradication","author":"Fenner","year":"1988"},{"key":"10.1331\/JAPhA.2009.09522_bb0045","series-title":"ACAM 2000 prescribing information","author":"Acambis, Inc.","year":"2008"},{"key":"10.1331\/JAPhA.2009.09522_bb0050","first-page":"1","article-title":"Smallpox vaccination and adverse reactions","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1331\/JAPhA.2009.09522_bb0055","series-title":"Emergency preparedness and response: what to do after you've gotten the smallpox vaccine","author":"Centers for Disease Control and Prevention","year":"2008"},{"key":"10.1331\/JAPhA.2009.09522_bb0060","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1331\/JAPhA.2009.09522_bb0065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"10.1331\/JAPhA.2009.09522_bb0070","first-page":"1024","article-title":"Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1331\/JAPhA.2009.09522_bb0075","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure for anthrax: adverse events and adherence","volume":"8","author":"Shepard","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"10.1331\/JAPhA.2009.09522_bb0080","series-title":"Summary report: October 22\u201323, 2008, Atlanta, Georgia","author":"Advisory Committee on Immunization Practices","year":"2009"},{"key":"10.1331\/JAPhA.2009.09522_bb0085","first-page":"889","article-title":"Update: investigation of anthrax associated with intentional exposure and interim public health guidelines","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1331\/JAPhA.2009.09522_bb0090","series-title":"BioThrax prescribing information","author":"Emergent Biosolutions","year":"2009"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115310384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115310384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T10:22:47Z","timestamp":1558434167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115310384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1544319115310384"],"URL":"https:\/\/doi.org\/10.1331\/japha.2009.09522","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}